 | Up a level |
Sacco, R; Disanto, G; Maraffi, I; Candrian, U; Kamm, Christian Philipp; Rossi, S; Schwegler, G; Gallo, A; Gobbi, C; Zecca, C (2020). Infusion-related reactions during Natalizumab treatment: Do we still need a post-infusion observation period? Multiple Sclerosis and Related Disorders, 38, p. 101523. Elsevier 10.1016/j.msard.2019.101523
